There has been considerable increase in maxillofacial and orbital injuries due to road traffic accidents, falls and assaults. There is need for accurate detection of these maxillofacial bony fractures. MDCT is the method of choice in the evaluation of maxillofacial traumas, as it allows accurate determination of the presence, location and extent of fractures especially in cases of communited fractures, rotational deformities and multiple bone fractures also having advantage to diagnose even in patients with facial edema, lacerations and altered sensorium. PURPOSE: The objective of the study is to compare axial, coronal and 3D reformatted CT images for the study of maxillofacial and orbital fractures. MATERIALS AND METHODS: Multislice CT scan was done for 131 patients attending BTGH Gulbarga with history of maxillofacial and orbital trauma during the period of December 2012 to September 2014 using Philips Brilliance 6 slice CT scanner. RESULTS: Majority of the patients were males (85.5%) belonged to age group of 21-30 years (42%). Most common cause of maxillofacial trauma was road traffic accident (78.6%). Fractures of nasal bones were most common followed by walls of maxillary sinuses and least common fractured bone was cribriform plate. Most common type of complex fracture was naso-ethmoido-orbital complex fracture followed by zygomaticomaxillary complex. Lateral wall of the orbit was most commonly fractured followed by medial wall and floor. DISCUSSION: Axial CT was better in diagnosing anterior maxillary wall, zygomatic arch fractures. Coronal CT was better in detecting orbital floor, Orbital roof, Pterygoid plate fractures, Classification of Le Fort fractures and orbital floor blow out fractures. 3D CT was slightly better to 2D CT in evaluating anterior maxillary wall fractures and frontal bone fractures. 2D and 3D CT were almost similar in evaluating fractures of nasal bone, zygomatic bone and zygomatic arch fractures. 3D CT was inferior to 2D in medial wall of maxillary sinus, medial wall of orbit, pterygoid plate fractures. CONCLUSION: MDCT offers excellent spatial resolution, which in turn enables exquisite multiplanar reformations and 3-D reconstructions allowing enhanced diagnostic accuracy and surgical planning.
Tuberculosis is re-emergingasaglobalhealthproblem.Itisaslowlyprogressive,chronic,granulomatous infectioncausedby M.tuberculosiswhichusuallyaffectslungs,butcanalsoaffectotherorganslikeCVS,GI,CNS,SKINandEYES. Choroidal tubercles and tuberculomas are reported to be the most common intraocular manifestations of TB and the most commonintraocularclinicalpresentationappearstobeposterioruveitis. ThediagnosisofocularTBisconsideredinsettingsof1.IsolationofM.tuberculosisfromocularfluidsortissuespecimen.Byamicrobiologicalorhistopathologicalstudy,PCR. 2.AspresumedoculardiseasesuggestiveofTBwithprovensystemicactivedisease. 3.Presumedoculardiseasewithoutevidenceofactivesystemicdisease. DiagnosticCriteriaForPresumedIntraocularTbUveitiswere. 1.Ocular findings consistent with possible intraocular TB with no other cause of uveitis suggested by history of symptoms,or ancillarytestings. 2.StronglypositiveMANTOUX OR TUBERCULINSKINTESTING(>10mmareaofinduration/necrosis) 3.Responsetoantituberculartherapywithabsenceofrecurrences. The aims of our study were to evaluate prevalence of Mantoux positive in newly referred uveitis patients in whom systemic evaluationwasperformedandtoassesstheoutcomeoftreatmentforpresumedintraoculartuberculosisinselectedpatients. MATERIALANDMETHOD The studywas conductedin theRetinaClinic atUpgradeddepartmentof Ophthalmology,LLRM medicalcollege,Meerut,India.Itwasaprospective,noncomparative,interventionalcaseseries. PatientsofocularinflammationreferredtoRetinaClinicwhounderwentsystemicevaluationwereincludedinthestudy A total of patients who satisfy the inclusion criteria , underwent systemic evaluation which include blood tests, chest radiograph,and tuberculin skin testing (0.05 _g purified protein derivative in 0.1 ml,equivalent to 2.5 tuberculin units) Both erythema and induration was measured at 48 hours,and the result were judged to be positive if induration was more than 10 mm Antituberculosis therapyi.eisoniazid300mg/day,rifampin600mg/day,ethambutol 15mg/kg/day,andpyrazinamide25–30 mg /kg/ day for the first 2 months ,thereafter rifampin and isoniazid were used for another 4–7 months was initiated for patients who had clinical findings consistent with possible intraocular tuberculosis,a positive tuberculin skin test result Responsetotherapywasassessedintermsofincreaseordecreaseorresolution OBSERVATIONAND RESULT Ofthe total 32patients 9patients havepositive tubercular contact history and30patientswere mantouxpositive.(94%),ofwhich78%havetheirindurationsizeof>15mmand8patientshavepositivex-rayfindings.(25%) Out of these 32 patients, 25 received antituberculous therapy for 9 months. In addition all of these patients also received systemicprednisone(1mg/kg/day)untilaclinicaleffectwasseenandthenaslowreductionofdosewasdone. 7patientsweredroppedoutfromthestudy. Out of these 25 patients which were started on treatment, 24 patients (96%) showed improvement in their clinical status, 19 patients (76%) showed improvement in their visual acuity after treatment and 35.6 % patients attained visual acuity of 6/9 or better. CONCLUSION Treatment with antitubercular therapy combined with systemic corticosteroids induces resolution of inflammation with no recurrences. So, mantoux testing should remain an integral part of the systemic work-up for uveitis patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.